Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 13 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (6)

Trial Status

Completed11
Not Yet Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (13)

Research Network

Activity Timeline